Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2012
08/30/2012WO2012115241A1 Fcγriib-specific fc antibody
08/30/2012WO2012115222A1 Adjuvant for transdermal or transmucosal administration and pharmaceutical preparation containing same
08/30/2012WO2012114323A1 Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
08/30/2012WO2012113963A1 Use of p53 inhibitors for reducing food intake and lowering body weight
08/30/2012WO2012113921A1 Rapid selection method for hiv gp-120 variants
08/30/2012WO2012113813A1 Antibodies against human il33r and uses thereof
08/30/2012WO2012113783A1 Method for treating liver inflammation, fibrosis and non-alcoholic steatohepatitis.
08/30/2012WO2012113775A1 Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders
08/30/2012WO2012113348A1 Anti-cd4 protein monoclonal antibody, active fragments and uses thereof
08/30/2012WO2012113343A1 Use of il-17 inhibitor in preparation of drug for treating and/or preventing lung injury
08/30/2012WO2012113266A1 Antibody and antigen recognizing tumor-initiating cells and use thereof
08/30/2012WO2012113064A1 Method of diagnosing primary mediastinal b-cell lymphoma or classical hodgkin lymphoma by detecting functional mutation at ciita locus.
08/30/2012WO2012094623A3 Anti-il-12/il-23 antibodies and uses thereof
08/30/2012WO2012094540A3 Methods for preparation of glycosphingolipids and uses thereof
08/30/2012WO2012088125A3 Methods and compositions of protein antigens for the diagnosis and treatment of toxoplasma gondii infections and toxoplasmosis
08/30/2012WO2012087928A3 Modulating agonistic tnfr antibodies
08/30/2012WO2012085872A3 Stable immunogenic compositions of staphylococcus aureus antigens
08/30/2012WO2012083132A3 Diagnosis and treatments relating to th2 inhibition
08/30/2012WO2012082483A3 Multifunctional linkers and methods for the use thereof
08/30/2012WO2012065161A3 Antibodies to tumor endothelial marker 8
08/30/2012WO2012054929A3 Use of human serum albumin to decrease antigenicity of therapeutic proteins
08/30/2012WO2012054862A9 Agents, compositions, and methods for treating pruritis and related skin conditions
08/30/2012WO2012047341A9 Sapp-alpha as a biomarker for prediction of inflammatory and autoimmune-related disorders
08/30/2012WO2012017082A3 Anti-la antibodies and their use for immunotargeting
08/30/2012US20120222142 Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same
08/30/2012US20120220921 Immunologically modified carbon nanotubes for cancer treatment
08/30/2012US20120219956 Ngal for diagnosis of renal conditions
08/30/2012US20120219617 MUC1 Based Glycolipopeptide Vaccine with Adjuvant
08/30/2012US20120219615 Therapeutic Use of a TLR Agonist and Combination Therapy
08/30/2012US20120219614 Methods and compositions for preventing a condition
08/30/2012US20120219605 Adjuvanted nanoparticulate influenza vaccine
08/30/2012US20120219594 Benzimidazole-imidazole Derivatives
08/30/2012US20120219591 Use of vectors expressing intracellular polynucleotide binding proteins as adjuvants
08/30/2012US20120219590 Formulations useful for spray drying vaccines
08/30/2012US20120219589 Formulation of drugs and vaccines in the form of percutaneous injectable needles
08/30/2012US20120219588 Methods for purification of viruses
08/30/2012US20120219587 Process for producing influenza vaccine
08/30/2012US20120219586 Adjuvanted vaccine formulations
08/30/2012US20120219585 Influenza treatment and/or characterization, human-adapted ha polypeptides; vaccines
08/30/2012US20120219584 Protection against pandemic and seasonal strains of influenza
08/30/2012US20120219582 Intranasal spray-type tuberculosis vaccine using paramyxovirus vector
08/30/2012US20120219580 Highly pathogenic avian influenza virus protein vaccine derived from transgenic plant, and preparing method thereof
08/30/2012US20120219579 Virus like particles comprising target proteins fused to plant viral coat proteins
08/30/2012US20120219578 Neisserial antigenic peptides
08/30/2012US20120219577 Hiv-1 clade a consensus sequences, antigens, and transgenes
08/30/2012US20120219576 Lassa virus-like particles and methods of production thereof
08/30/2012US20120219575 Peptide Sequences and Compositions
08/30/2012US20120219574 Antigen surrogates in autoimmune disease
08/30/2012US20120219573 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
08/30/2012US20120219572 Spheroidal Aggregates of Mesenchymal Stem Cells
08/30/2012US20120219570 G-protein coupled receptor-associated sorting protein 1 as a cancer biomarker
08/30/2012US20120219569 Use of an anti-cd151 antibody in the treatment of cancer
08/30/2012US20120219568 Epidithiodioxopiprazines and uses thereof in treating cancer
08/30/2012US20120219567 Methods Relating to Peripheral Administration of Nogo Receptor Polypeptides
08/30/2012US20120219566 Compositions and methods of treating t cell mediated disorder
08/30/2012US20120219565 Engineered anti-tslp antibody
08/30/2012US20120219564 Human Antibodies That Bind Human TNFalpha
08/30/2012US20120219563 Fibroblast growth factor receptor-3 (fgfr-3) inhibitors and methods of treatment
08/30/2012US20120219562 METHODS OF TREATING PSORIASIS BY ADMINISTRATION OF ANTIBODIES TO THE p40 SUBUNIT OF IL-12 AND/OR IL-23
08/30/2012US20120219561 Prophylaxis Against Cancer Metastasis
08/30/2012US20120219560 DE-N-Acetyl Sialic Acid Antigens, Antibodies Thereto, and Methods of Use in Cancer Therapy
08/30/2012US20120219559 Methods of modulating immune function
08/30/2012US20120219558 Antagonists of pcsk9
08/30/2012US20120219557 Human monoclonal antibodies to protein tyrosine kinase 7 (ptk7) and methods for using anti-ptk7 antibodies
08/30/2012US20120219556 Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
08/30/2012US20120219555 Auto-antibody markers of autoimmune disease
08/30/2012US20120219554 Extracellular yaluronidase from streptomyces koganeiensis
08/30/2012US20120219553 Use of a cd258 binding pharmaceutical substrance for making a pharmaceutical composition with dose-dependent effect
08/30/2012US20120219552 Antibody recognizing turn structure in amyloid beta
08/30/2012US20120219551 Fc Region-Containing Polypeptides That Exhibit Improved Effector Function Due To Alterations Of The Extent Of Fucosylation, And Methods For Their Use
08/30/2012US20120219550 Pharmaceutical combinations comprising a pyrido [4,3-d] pyrimidine derived hsp90-inhibitor and a her2 inhibitor
08/30/2012US20120219549 Combination therapy of a type II anti-CD20 antibody with a proteasome inhibitor
08/30/2012US20120219548 PODXL Protein in Colorectal Cancer
08/30/2012US20120219547 Humanized Anti-TNFalpha Antibodies
08/30/2012US20120219546 Methods for treating conditions mediated by the inflammatory cytokine cascade using gapdh inhibitors
08/30/2012US20120219545 Materials and methods for diagnosing and treating shellfish allergy
08/30/2012US20120219544 Adhesive composition for soft tissues, adhesive composition for wound dressing or wound dressing composition
08/30/2012US20120219543 Methods and pharmaceutical compositions for the treatment of disorders of glucose homeostasis
08/30/2012US20120219542 Podocyte ph modulation and uses thereof
08/30/2012US20120219541 Therapeutic Compositions Comprising Monoterpenes
08/30/2012US20120219540 Compositions and methods for modulating immune responses
08/30/2012US20120219524 Antibodies that bind colony stimulating factor 1 receptor (csf1r)
08/30/2012US20120219522 Substituted quinoline compounds and methods of use
08/30/2012US20120219504 Complex of a protein comprising zinc oxide-binding peptides and zinc oxide nanoparticles, and use thereof
08/30/2012US20120219503 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
08/30/2012US20120219502 Methods and compositions for targeting gc1qr/p32
08/30/2012US20120219501 Biomarker en2 for gynaecological cancer
08/30/2012US20120219497 Random ethylene oxide and non-random alkylene oxide(s) polymers
08/30/2012US20120219495 Novel tetraaza macrocyclic compound, preparation method thereof and use thereof
08/30/2012CA2828443A1 Combined cell based gp96-ig-siv/hiv, recombinant gp120 protein vaccination for protection from siv/hiv
08/30/2012CA2828255A1 Protein nanocarriers for topical delivery
08/30/2012CA2828248A1 Formulations useful for spray drying vaccines
08/30/2012CA2828192A1 Exogenous internal positive control
08/30/2012CA2828099A1 Combination therapies comprising anti-erbb3 agents
08/30/2012CA2828068A1 Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
08/30/2012CA2827967A1 Rapid selection method for hiv gp-120 variants
08/30/2012CA2827923A1 Fc.gamma.riib-specific fc antibody
08/30/2012CA2825972A1 Muc1 based glycolipopeptide vaccine with adjuvant
08/30/2012CA2824500A1 Antibodies against human il33r and uses thereof
08/29/2012EP2492279A1 Rapid immunogen selection method using lentiviral display
1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 1823